BVS vs. ACRV

Last updated Jun 3, 2026

BVS (Bioventus Inc.) and ACRV (Acrivon Therapeutics Inc. Common Stock) are both stocks. Both are in the Healthcare sector — BVS in Medical Devices, ACRV in Biotechnology. Over the past 3 years, BVS returned 39.93%/yr vs -49.75%/yr for ACRV. At a 0.15 correlation, their price movements are largely independent.

Performance

BVS vs. ACRV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bioventus Inc. (BVS) and Acrivon Therapeutics Inc. Common Stock (ACRV). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BVS achieves a 9.01% return, which is significantly higher than ACRV's -34.85% return.

BVS

• 1D: 2.27%
• 1M: -19.78%
• YTD: 9.01%
• 6M: 7.28%
• 1Y: 25.93%
• 3Y*: 39.93%
• 5Y*: -14.50%
• 10Y*: —

ACRV

• 1D: 0.64%
• 1M: -24.88%
• YTD: -34.85%
• 6M: -28.64%
• 1Y: 41.44%
• 3Y*: -49.75%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BVS vs. ACRV - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
BVS Bioventus Inc.	9.01%	-29.14%	99.24%	101.92%	-20.43%
ACRV Acrivon Therapeutics Inc. Common Stock	-34.85%	-59.97%	22.36%	-57.29%	-30.77%

Correlation

The correlation between BVS and ACRV is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.22
Correlation (3Y) Calculated over the trailing 3-year period	0.17
Correlation (All Time) Calculated using the full available price history since Nov 16, 2022	0.15

Fundamentals

Market Cap BVS : $567.77M ACRV : $60.80M
EPS BVS : $0.41 ACRV : -$2.00
PB Ratio BVS : 3.01 ACRV : 0.64
Total Revenue (TTM) BVS : $576.30M ACRV : $0.00
Gross Profit (TTM) BVS : $390.14M ACRV : $311.00K
EBITDA (TTM) BVS : $98.72M ACRV : -$84.65M

Return for Risk

BVS vs. ACRV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BVS

BVS Risk / Return Rank: 59
BVS Sharpe Ratio Rank: 58
BVS Sortino Ratio Rank: 56
BVS Omega Ratio Rank: 55
BVS Calmar Ratio Rank: 59
BVS Martin Ratio Rank: 68

ACRV

ACRV Risk / Return Rank: 58
ACRV Sharpe Ratio Rank: 56
ACRV Sortino Ratio Rank: 61
ACRV Omega Ratio Rank: 60
ACRV Calmar Ratio Rank: 58
ACRV Martin Ratio Rank: 57

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BVS vs. ACRV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bioventus Inc. (BVS) and Acrivon Therapeutics Inc. Common Stock (ACRV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BVS	ACRV	Difference
Sharpe ratio Return per unit of total volatility	0.52	0.45	+0.07
Sortino ratio Return per unit of downside risk	1.14	1.32	-0.19
Omega ratio Gain probability vs. loss probability	1.14	1.17	-0.03
Calmar ratio Return relative to maximum drawdown	0.91	0.87	+0.05
Martin ratio Return relative to average drawdown	3.41	1.77	+1.65
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BVS vs. ACRV - Sharpe Ratio Comparison

The current BVS Sharpe Ratio is 0.52, which is comparable to the ACRV Sharpe Ratio of 0.45. The chart below compares the historical Sharpe Ratios of BVS and ACRV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	BVS	ACRV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.52	0.45	+0.07
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.18	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.19	-0.47	+0.28

Drawdowns

BVS vs. ACRV - Drawdown Comparison

The maximum BVS drawdown since its inception was -95.18%, roughly equal to the maximum ACRV drawdown of -95.47%. Use the drawdown chart below to compare losses from any high point for BVS and ACRV.

Drawdown Indicators

	BVS	ACRV	Difference
Max Drawdown Largest peak-to-trough decline	-95.18%	-95.47%	+0.29%
Max Drawdown (1Y) Largest decline over 1 year	-27.51%	-57.14%	+29.63%
Max Drawdown (3Y) Largest decline over 3 years	-55.22%	-92.31%	+37.09%
Max Drawdown (5Y) Largest decline over 5 years	-95.07%	—	—
Current Drawdown Current decline from peak	-57.78%	-93.23%	+35.45%
Average Drawdown Average peak-to-trough decline	-56.39%	-70.39%	+14.00%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.37%	28.03%	-20.66%

Volatility

BVS vs. ACRV - Volatility Comparison

Bioventus Inc. (BVS) has a higher volatility of 18.59% compared to Acrivon Therapeutics Inc. Common Stock (ACRV) at 17.27%. This indicates that BVS's price experiences larger fluctuations and is considered to be riskier than ACRV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BVS	ACRV	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.59%	17.27%	+1.32%
Volatility (6M) Calculated over the trailing 6-month period	32.52%	73.74%	-41.22%
Volatility (1Y) Calculated over the trailing 1-year period	50.31%	92.51%	-42.20%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	81.01%	103.93%	-22.92%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	80.08%	103.93%	-23.85%

Dividends

BVS vs. ACRV - Dividend Comparison

Neither BVS nor ACRV has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both BVS and ACRV in my portfolio?

BVS and ACRV have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BVS or ACRV?

BVS has higher volatility (18.59%) compared to ACRV (17.27%). In terms of maximum drawdown, BVS dropped -95.18% vs ACRV's -95.47%.

Which has better risk-adjusted returns?

BVS currently has the higher Sharpe Ratio (0.52 vs 0.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.